Validation and Standardization of Serologic Methods for Evaluation of Clinical Immune Response to Vaccines
- 29 July 1998
- book chapter
- Published by Taylor & Francis
Abstract
No abstract availableThis publication has 141 references indexed in Scilit:
- Definition of Minimum Standards for Immunogenicity—Potential Problems of Serological Correlates—Possible Interference: Serological Correlates for Diphtheria-Tetanus-Whole Cell Pertussis VaccinesBiologicals, 1994
- Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk childrenThe Journal of Pediatrics, 1993
- The second international standard for anti-poliovirus sera types 1, 2 and 3Biologicals, 1992
- Determination of antibodies to pertussis toxin in working reference preparations of anti-pertussis sera from various national control laboratoriesBiologicals, 1992
- The Role of Natural Killer Cells in Immune SurveillanceNew England Journal of Medicine, 1989
- Elisa for Human IgG and IpM Anti-Lipopolysaccharide Antibodies with Indirect StandardizationJournal of Immunoassay, 1987
- Prevention ofHaemophilus influenzaeType b Infections in High-Risk Infants Treated with Bacterial Polysaccharide Immune GlobulinNew England Journal of Medicine, 1987
- Immune response to pneumococcal vaccine: Two usesClinical Immunology Newsletter, 1982
- Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of AgeNew England Journal of Medicine, 1977
- The development of immunoglobulinlevels in manThe Journal of Pediatrics, 1968